- Selective Targeting and Eradication of Various Human Non-Small Cell Lung Cancer Cell Lines Using Self-Assembled Aptamer-Decorated Nanoparticles
Daniel Barak et al, 2022, Pharmaceutics CrossRef - Inhibition of HSP90 by AUY922 Preferentially Kills Mutant KRAS Colon Cancer Cells by Activating Bim through ER Stress
Chun Yan Wang et al, 2016, Molecular Cancer Therapeutics CrossRef - Inhibition of Ubiquitin-specific Peptidase 8 Suppresses Growth of Gefitinib-resistant Non-small Cell Lung Cancer Cells by Inducing Apoptosis
Chul-Ho Jeong, 2015, Journal of Cancer Prevention CrossRef - Mechanisms of resistance to EGFR tyrosine kinase inhibitors
Lihua Huang et al, 2015, Acta Pharmaceutica Sinica B CrossRef - Heat Shock Protein 90 Inhibitors in Lung Cancer Therapy
Suman Chatterjee et al, 2019, Heat Shock Proteins in Signaling Pathways CrossRef - Targeting MERTK and AXL in EGFR Mutant Non-Small Cell Lung Cancer
Dan Yan et al, 2021, Cancers CrossRef - Extracellular region of epidermal growth factor receptor: a potential target for anti-EGFR drug discovery
A Dokala et al, 2017, Oncogene CrossRef - Chaperoning STAT3/5 by Heat Shock Proteins: Interest of Their Targeting in Cancer Therapy
Gaëtan Jego et al, 2019, Cancers CrossRef - Effects of Ephedra Herb extract on the expression of EGFR-activating mutations and c-Met in non-small-cell lung cancer cell line, H1975, and its combined effects with osimertinib
Eiko Mori et al, 2023, Journal of Natural Medicines CrossRef - EGFR Mutation Positive Stage IV Non-Small-Cell Lung Cancer: Treatment Beyond Progression
Katrijn Van Assche et al, 2014, Frontiers in Oncology CrossRef - Heat Shock Protein 90 and Reproduction in Female Animals: Ovary, Oocyte and Early Embryo
Yu-Wei Yang et al, 2019, Heat Shock Protein 90 in Human Diseases and Disorders CrossRef - Development of Heat Shock Protein (Hsp90) Inhibitors To Combat Resistance to Tyrosine Kinase Inhibitors through Hsp90–Kinase Interactions
Meining Wang et al, 2016, Journal of Medicinal Chemistry CrossRef